Cytosorbents Corp Quarterly Operating Income (Loss) in USD from Q1 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cytosorbents Corp quarterly/annual Operating Income (Loss) history and growth rate from Q1 2011 to Q3 2024.
  • Cytosorbents Corp Operating Income (Loss) for the quarter ending September 30, 2024 was -$4.4M, a 40.2% increase year-over-year.
  • Cytosorbents Corp Operating Income (Loss) for the twelve months ending September 30, 2024 was -$22.1M, a 21.3% increase year-over-year.
  • Cytosorbents Corp annual Operating Income (Loss) for 2023 was -$31.2M, a 0.99% increase from 2022.
  • Cytosorbents Corp annual Operating Income (Loss) for 2022 was -$31.5M, a 38.6% decline from 2021.
  • Cytosorbents Corp annual Operating Income (Loss) for 2021 was -$22.7M, a 119% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$22.1M -$4.4M +$2.95M +40.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$25.1M -$3.42M +$3.14M +47.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$28.2M -$4.93M +$2.97M +37.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$31.2M -$9.41M -$3.05M -48% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 -$28.2M -$7.35M +$1.67M +18.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$29.8M -$6.56M +$1.8M +21.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$31.6M -$7.89M -$100K -1.29% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$31.5M -$6.36M +$3.21M +33.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 -$34.7M -$9.02M -$3.61M -66.8% Jul 1, 2022 Sep 30, 2022 10-K 2024-03-15
Q2 2022 -$31.1M -$8.36M -$3.43M -69.7% Apr 1, 2022 Jun 30, 2022 10-K 2024-03-15
Q1 2022 -$27.7M -$7.79M -$4.94M -173% Jan 1, 2022 Mar 31, 2022 10-K 2024-03-15
Q4 2021 -$22.7M -$9.56M -$6.93M -263% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-15
Q3 2021 -$15.8M -$5.41M -$3.45M -176% Jul 1, 2021 Sep 30, 2021 10-K 2024-03-15
Q2 2021 -$12.4M -$4.92M -$1.63M -49.3% Apr 1, 2021 Jun 30, 2021 10-K 2024-03-15
Q1 2021 -$10.7M -$2.85M -$373K -15.1% Jan 1, 2021 Mar 31, 2021 10-K 2024-03-15
Q4 2020 -$10.4M -$2.63M +$2.8M +51.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-09
Q3 2020 -$13.2M -$1.96M +$3.67M +65.2% Jul 1, 2020 Sep 30, 2020 10-K 2023-03-09
Q2 2020 -$16.8M -$3.3M +$332K +9.16% Apr 1, 2020 Jun 30, 2020 10-K 2023-03-09
Q1 2020 -$17.2M -$2.48M +$1.81M +42.2% Jan 1, 2020 Mar 31, 2020 10-K 2023-03-09
Q4 2019 -$19M -$5.43M +$154K +2.76% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-10
Q3 2019 -$19.1M -$5.63M -$2.92M -108% Jul 1, 2019 Sep 30, 2019 10-K 2022-03-10
Q2 2019 -$16.2M -$3.63M +$558K +13.3% Apr 1, 2019 Jun 30, 2019 10-K 2022-03-10
Q1 2019 -$16.8M -$4.29M -$1.18M -38.2% Jan 1, 2019 Mar 31, 2019 10-K 2022-03-10
Q4 2018 -$15.6M -$5.59M -$1.78M -46.8% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-09
Q3 2018 -$13.8M -$2.71M -$562K -26.1% Jul 1, 2018 Sep 30, 2018 10-K 2021-03-09
Q2 2018 -$13.2M -$4.19M -$1.86M -79.7% Apr 1, 2018 Jun 30, 2018 10-K 2021-03-09
Q1 2018 -$11.4M -$3.1M -$1.54M -99.1% Jan 1, 2018 Mar 31, 2018 10-K 2021-03-09
Q4 2017 -$9.84M -$3.81M +$765K +16.7% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-05
Q3 2017 -$10.6M -$2.15M -$4.83K -0.23% Jul 1, 2017 Sep 30, 2017 10-K 2020-03-05
Q2 2017 -$10.6M -$2.33M +$356K +13.3% Apr 1, 2017 Jun 30, 2017 10-K 2020-03-05
Q1 2017 -$11M -$1.56M +$533K +25.5% Jan 1, 2017 Mar 31, 2017 10-K 2020-03-05
Q4 2016 -$11.5M -$4.57M -$2.36M -106% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-07
Q3 2016 -$9.14M -$2.14M +$6.08K +0.28% Jul 1, 2016 Sep 30, 2016 10-K 2019-03-07
Q2 2016 -$9.14M -$2.69M -$460K -20.6% Apr 1, 2016 Jun 30, 2016 10-K 2019-03-07
Q1 2016 -$8.68M -$2.09M +$622K +22.9% Jan 1, 2016 Mar 31, 2016 10-K 2019-03-07
Q4 2015 -$9.3M -$2.21M +$677K +23.4% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-08
Q3 2015 -$9.98M -$2.15M -$667K -44.9% Jul 1, 2015 Sep 30, 2015 10-K 2018-03-08
Q2 2015 -$9.31M -$2.23M -$864K -63.4% Apr 1, 2015 Jun 30, 2015 10-K 2018-03-08
Q1 2015 -$8.45M -$2.71M -$1.56M -135% Jan 1, 2015 Mar 31, 2015 10-K 2018-03-08
Q4 2014 -$6.89M -$2.89M -$1.89M -188% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-03
Q3 2014 -$5.01M -$1.48M -$604K -68.6% Jul 1, 2014 Sep 30, 2014 10-K 2017-03-03
Q2 2014 -$4.4M -$1.36M +$43.5K +3.09% Apr 1, 2014 Jun 30, 2014 10-K 2017-03-03
Q1 2014 -$4.45M -$1.15M +$268K +18.8% Jan 1, 2014 Mar 31, 2014 10-K 2017-03-03
Q4 2013 -$4.71M -$1M -$191K -23.5% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 -$4.52M -$880K -$279K -46.4% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$4.24M -$1.41M -$397K -39.4% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 -$3.85M -$1.42M -$355K -33.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$3.49M -$813K +$156K +16.1% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 -$3.65M -$601K +$625K +51% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-06
Q2 2012 -$4.27M -$1.01M +$105K +9.39% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$4.38M -$1.07M +$61.3K +5.43% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$4.44M -$968K Oct 1, 2011 Dec 31, 2011 10-K 2013-04-03
Q3 2011 -$1.23M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-21
Q2 2011 -$1.11M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-13
Q1 2011 -$1.13M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.